When did Glaukos report Q1 2025 earnings?

Glaukos (GKOS) reported Q1 2025 earnings on April 30, 2025 after market close.

What were Glaukos's Q1 2025 revenue and EPS?

Glaukos reported revenue of $106.7M and eps of $-0.22 for Q1 2025.

Did Glaukos beat estimates in Q1 2025?

Revenue beat the consensus estimate of $102.8M by $3.9M. EPS beat the consensus estimate of $-0.33 by $0.11.

How did Glaukos's Q1 2025 results compare year-over-year?

Compared to the same quarter a year prior, revenue grew 24.6% from $85.6M a year earlier and eps grew 68.6% from $-0.70.

Where can I find Glaukos's Q1 2025 SEC filings?

You can read the 10-Q periodic report (0001558370-25-006041) directly on SEC EDGAR. The filing index links above go to sec.gov.

Glaukos GKOS Q1 2025 earnings

Reported April 30, 2025 · After market close

Revenue$106.7MBeat by $3.9M

EPS-$0.22Beat by $0.11

Revenue estimate$102.8M

EPS estimate-$0.33

Next report

Date not yet announced

Financials

Q1 2025

Income statement

See full

Revenue$106.7M+24.6%

Gross profit$82.3M+26.0%

Operating income-$20.7M+47.1%

Net income-$18.1M+55.6%

EPS (diluted)-$0.32+61.0%

Balance sheet

See full

Cash & equivalents$114.3M+169%

Total debt$107.7M+4.9%

Total equity$764.0M+69.5%

Total assets$966.2M+3.5%

Cash flow

See full

Operating cash flow-$18.5M+45.3%

CapEx$1.9M+100%

Free cash flow-$20.5M+41.3%

Valuation & ratios

Valuation

as of 03/31/25

See full

Market cap$5.57B+19.4%

Enterprise value$5.56B+17.7%

P/S13.8×-0.5×

Profitability

See full

Gross margin75.8%-0.4pp

Operating margin-25.7%-7.0pp

Net margin-30.6%-6.9pp

FCF margin-13.2%-3.9pp

Returns & leverage

See full

Return on equity-20.4%-4.8pp

Debt / equity0.1×-0.1×

Current ratio6.5×+1.1×

Segments

By product

See full

Glaucoma$88.1M+31.1%

Corneal Health$18.5M+0.7%

By segment

See full

Development And Commercialization Of Ophthalmic Therapies$106.7M+24.6%

By geography

See full

US$75.1M—

Versus estimates

Revenue

Q2 2026$185.6MBeat by $34.7M Q1 2026$150.6MBeat by $13.6M Q4 2025$143.1MBeat by $6.7M Q3 2025$133.5MBeat by $4.1M Q2 2025$124.1MBeat by $1.7M

Q1 2025$106.7MBeat by $3.9M

Diluted EPS

Q2 2026-$0.14Beat by $0.07 Q1 2026-$0.18Beat by $0.12 Q4 2025-$0.28Miss by $0.06 Q3 2025-$0.16Beat by $0.11 Q2 2025-$0.24Beat by $0.02

Q1 2025-$0.22Beat by $0.11

Ask the moment Glaukos reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI

Claude

Questions, answered.

When did Glaukos report Q1 2025 earnings?: Glaukos (GKOS) reported Q1 2025 earnings on April 30, 2025 after market close.
What were Glaukos's Q1 2025 revenue and EPS?: Glaukos reported revenue of $106.7M and eps of $-0.22 for Q1 2025.
Did Glaukos beat estimates in Q1 2025?: Revenue beat the consensus estimate of $102.8M by $3.9M. EPS beat the consensus estimate of $-0.33 by $0.11.
How did Glaukos's Q1 2025 results compare year-over-year?: Compared to the same quarter a year prior, revenue grew 24.6% from $85.6M a year earlier and eps grew 68.6% from $-0.70.
Where can I find Glaukos's Q1 2025 SEC filings?: You can read the 10-Q periodic report (0001558370-25-006041) directly on SEC EDGAR. The filing index links above go to sec.gov.